Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Platelet-derived Integrin- and Tetraspanin-enriched Tethers as key effectors in thrombo-Inflammation

Project description

Research uncovers platelet role in inflammation and immune response

Platelets, known for their role in stopping bleeding (haemostasis) and forming clots (thrombosis), are now increasingly recognised as key regulators of immune responses and inflammation. They influence immune cell trafficking and endothelial barrier function and protect organ integrity, but they can also lead to organ damage in conditions like stroke and sepsis. A groundbreaking discovery reveals that platelets can reorganise their main adhesion receptor along with a signalling machinery into so-called disintegration complexes, which form a new organelle known as ‘platelet-derived integrin and tetraspanin-enriched tether’ (PITT). These PITTs, packed with immune-modulatory proteins and RNA, can provoke thrombo-inflammation. The ERC-funded PITT-Inflame project aims to explore these mechanisms and develop new therapies. Understanding this process may transform how various diseases are treated.

Objective

Platelets are mediators of haemostasis and thrombosis, but also increasingly recognized as versatile effector cells of innate immunity. The concept of thrombo-inflammation recognizes that thrombotic and inflammatory pathomechanisms are closely intertwined. Platelets thereby act as central orchestrators of immune cell trafficking, vascular barrier function and organ integrity and contribute to organ injury in severe disorders with limited treatment options (e.g. stroke, sepsis, ARDS). The underlying molecular mechanisms are not known.
I recently discovered an unexpected novel effector mechanism in platelets with potentially huge impact for understanding these cells in health and disease: Resting platelets can rapidly reorganize the entire pool of their principal adhesion receptor, integrin IIb3, along with its associated tetraspanins and signalling machinery into disintegration complexes (DISCs) in distinct membrane microdomains. These DISCS serve as building blocks for a novel organelle, the Platelet-derived Integrin and Tetraspanin-enriched Tether (PITT). PITTs are loaded with signalling molecules, ribosomes and RNA and can segregate from the platelet to promote thrombo-inflammation. Also 1-integrins as well as glycoprotein (GP)VI can be integrated into DISCs and deposited at discrete adhesion points.
I therefore postulate that circulating platelets have the capacity to use their principal adhesion/signalling machineries in two fundamentally different ways and thereby switch between the haemostatic and a thrombo-inflammatory effector programme. If proven correct, this would implicate a radically new paradigm in platelet biology, and open new avenues for the treatment of a wide range of diseases with major societal impact.
PITT-Inflame will (i) provide a detailed molecular composition and architecture of DISCs and PITTs; (ii) decipher underlying signalling networks; (iii) identify PITT-induced effects on target cells and (iv) deduce therapeutic strategies.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2023-ADG

See all projects funded under this call

Host institution

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 499 250,00
Address
JOSEF-SCHNEIDER-STRASSE 2
97080 WURZBURG
Germany

See on map

Region
Bayern Unterfranken Würzburg, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 499 250,00

Beneficiaries (1)

My booklet 0 0